| Name | chorionic gonadotropin, beta polypeptide 5 |
| Description | This gene is a member of the glycoprotein hormone beta chain family and encodes the beta 5 subunit of chorionic gonadotropin (CG). Glycoprotein hormones are heterodimers consisting of a common alpha subunit and an unique beta subunit which confers biological specificity. CG is produced by the trophoblastic cells of the placenta and stimulates the ovaries to synthesize the steroids that are essential for the maintenance of pregnancy. The beta subunit of CG is encoded by 6 genes which are arranged in tandem and inverted pairs on chromosome 19q13.3 and contiguous with the luteinizing hormone beta subunit gene. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n The chorionic gonadotropin β‐subunit gene CGB5 encodes one of the major protein components of the heterodimeric human chorionic gonadotropin (hCG) hormone that is secreted by placental trophoblasts. Its product is essential for early pregnancy establishment and maintenance by supporting embryo implantation, trophoblast differentiation, and modulation of maternal immune and apoptotic responses. Variations in the gene – whether due to genetic polymorphisms, missense mutations, or epigenetic alterations – can alter the assembly, secretion, and downstream signaling activity of hCG. For example, certain promoter variants and missense mutations in CGB5 may decrease or modify hCG dimer formation yet, in some instances, trigger compensatory receptor signaling; such alterations have been associated with changes in risks for recurrent miscarriage and other adverse pregnancy outcomes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In addition to its canonical reproductive functions, aberrant or ectopic expression of CGB5 has been reported in several malignancies. Elevated levels of hCGβ derived from CGB5 have been linked to tumor initiation, growth, invasion, and poor prognosis in cancers such as breast, ovarian, testicular, and gastric cancer, suggesting that hCGβ may act as a paracrine or autocrine growth modulator in these tissues."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "12"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Moreover, regulation of CGB5 expression is complex. Transcriptional repressors such as MTA3 have been shown to bind directly to the promoter regions of hCG β‐subunit genes, thereby influencing trophoblast differentiation and the balance of cell lineage markers; dysregulation in this control mechanism has been implicated in pregnancy complications like preeclampsia."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": " In some contexts, autoantibodies directed against CGB5 have also been identified and may serve as biomarkers for recurrent glomerular disorders post‐transplantation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these findings emphasize that CGB5 is not only central to normal placental and reproductive function through its role in hCG production but that its dysregulation can contribute to a spectrum of clinical conditions ranging from adverse pregnancy outcomes to oncogenic processes.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Kristiina Rull, Liina Nagirnaja, Veli-Matti Ulander, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chorionic gonadotropin beta-gene variants are associated with recurrent miscarriage in two European populations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2008-1101"}], "href": "https://doi.org/10.1210/jc.2008-1101"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18782867"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18782867"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Liis Uusküla, Kristiina Rull, Liina Nagirnaja, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methylation allelic polymorphism (MAP) in chorionic gonadotropin beta5 (CGB5) and its association with pregnancy success."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2010-1647"}], "href": "https://doi.org/10.1210/jc.2010-1647"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20962020"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20962020"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Liina Nagirnaja, Česlovas Venclovas, Kristiina Rull, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural and functional analysis of rare missense mutations in human chorionic gonadotrophin β-subunit."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Hum Reprod (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/molehr/gas018"}], "href": "https://doi.org/10.1093/molehr/gas018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22554618"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22554618"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Kristiina Rull, Ole Bjarne Christiansen, Liina Nagirnaja, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A modest but significant effect of CGB5 gene promoter polymorphisms in modulating the risk of recurrent miscarriage."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Fertil Steril (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.fertnstert.2013.02.019"}], "href": "https://doi.org/10.1016/j.fertnstert.2013.02.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23499152"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23499152"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yong Sun, Xuan Ji "}, {"type": "b", "children": [{"type": "t", "text": "Association of rs7260002 of chorionic gonadotrophin β5 with idiopathic recurrent spontaneous abortion in Chinese population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Assist Reprod Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10815-014-0321-1"}], "href": "https://doi.org/10.1007/s10815-014-0321-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25193288"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25193288"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yu Chen, Muhammad G Kibriya, Farzana Jasmine, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Do placental genes affect maternal breast cancer? Association between offspring's CGB5 and CSH1 gene variants and maternal breast cancer risk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-08-2243"}], "href": "https://doi.org/10.1158/0008-5472.CAN-08-2243"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19047151"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19047151"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Finn Edler von Eyben, Jorge Parraga-Alava, Shi-Ming Tu "}, {"type": "b", "children": [{"type": "t", "text": "Testicular germ cell tumors type 2 have high RNA expression of "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "LDHB"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": ", the gene for lactate dehydrogenase subunit B."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Asian J Androl (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4103/aja.aja_4_21"}], "href": "https://doi.org/10.4103/aja.aja_4_21"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33565425"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33565425"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Mirosław Andrusiewicz, Izabela Skibińska, Emilia Gąsiorowska, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fluorescence resonance energy transfer usage to track the sequence promoter changes in CGB5 gene in ovarian cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2017.02.113"}], "href": "https://doi.org/10.1016/j.biopha.2017.02.113"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28355589"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28355589"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Anna Szczerba, Aleksandra Śliwa, Marta Kubiczak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human chorionic gonadotropin β subunit affects the expression of apoptosis-regulating factors in ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2015.4386"}], "href": "https://doi.org/10.3892/or.2015.4386"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26530886"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26530886"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Min Qin, Zhihai Liang, Heping Qin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel Prognostic Biomarkers in Gastric Cancer: CGB5, MKNK2, and PAPPA2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Oncol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fonc.2021.683582"}], "href": "https://doi.org/10.3389/fonc.2021.683582"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34222004"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34222004"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Xin Xu, Yida Lu, Youliang Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A signature of seven immune-related genes predicts overall survival in male gastric cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell Int (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12935-021-01823-0"}], "href": "https://doi.org/10.1186/s12935-021-01823-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33602220"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33602220"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "S K Sengodan, R Nadhan, R S Nair, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BRCA1 regulation on β-hCG: a mechanism for tumorigenicity in BRCA1 defective breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogenesis (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/oncsis.2017.75"}], "href": "https://doi.org/10.1038/oncsis.2017.75"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28869585"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28869585"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Ying Chen, Jun Miyazaki, Haruki Nishizawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MTA3 regulates CGB5 and Snail genes in trophoblast."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2013.02.102"}], "href": "https://doi.org/10.1016/j.bbrc.2013.02.102"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23510993"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23510993"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Mariko Horii, Matteo Moretto-Zita, Katharine K Nelson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MTA3 regulates differentiation of human cytotrophoblast stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Placenta (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.placenta.2015.07.122"}], "href": "https://doi.org/10.1016/j.placenta.2015.07.122"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26198267"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26198267"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Maurizio Salvadori, Aris Tsalouchos "}, {"type": "b", "children": [{"type": "t", "text": "Therapeutic apheresis in kidney transplantation: An updated review."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "World J Transplant (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.5500/wjt.v9.i6.103"}], "href": "https://doi.org/10.5500/wjt.v9.i6.103"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31750088"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31750088"}]}]}]}
|
| Synonyms | CGB |
| NCBI Gene ID | 93659 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
CGB5 has 1,534 functional associations with biological entities spanning 6 categories (molecular profile, functional term, phrase or reference, disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 46 datasets.
Click the + buttons to view associations for CGB5 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of CGB5 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of CGB5 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of CGB5 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of CGB5 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of CGB5 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of CGB5 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of CGB5 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing CGB5 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing CGB5 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with CGB5 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with CGB5 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of CGB5 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with CGB5 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with CGB5 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for CGB5 protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with CGB5 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with CGB5 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with CGB5 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with CGB5 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at CGB5 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of CGB5 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of CGB5 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GAD Gene-Disease Associations | diseases associated with CGB5 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with CGB5 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with CGB5 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing CGB5 from the GeneSigDB Published Gene Signatures dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of CGB5 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of CGB5 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of CGB5 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of CGB5 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with CGB5 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of CGB5 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of CGB5 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of CGB5 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of CGB5 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving CGB5 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving CGB5 protein from the Wikipathways PFOCR 2024 dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of CGB5 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of CGB5 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of CGB5 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of CGB5 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of CGB5 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of CGB5 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of CGB5 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with CGB5 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with CGB5 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |